Acute Effects of High-Fat Meals Enriched With Walnuts or Olive Oil on Postprandial Endothelial Function

Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Journal of the American College of Cardiology (Impact Factor: 15.34). 11/2006; 48(8):1666-71. DOI: 10.1016/j.jacc.2006.06.057
Source: PubMed

ABSTRACT We sought to investigate whether the addition of walnuts or olive oil to a fatty meal have differential effects on postprandial vasoactivity, lipoproteins, markers of oxidation and endothelial activation, and plasma asymmetric dimethylarginine (ADMA).
Compared with a Mediterranean diet, a walnut diet has been shown to improve endothelial function in hypercholesterolemic patients. We hypothesized that walnuts would reverse postprandial endothelial dysfunction associated with consumption of a fatty meal.
We randomized in a crossover design 12 healthy subjects and 12 patients with hypercholesterolemia to 2 high-fat meal sequences to which 25 g olive oil or 40 g walnuts had been added. Both test meals contained 80 g fat and 35% saturated fatty acids, and consumption of each meal was separated by 1 week. Venipunctures and ultrasound measurements of brachial artery endothelial function were performed after fasting and 4 h after test meals.
In both study groups, flow-mediated dilation (FMD) was worse after the olive oil meal than after the walnut meal (p = 0.006, time-period interaction). Fasting, but not postprandial, triglyceride concentrations correlated inversely with FMD (r = -0.324; p = 0.024). Flow-independent dilation and plasma ADMA concentrations were unchanged, and the concentration of oxidized low-density lipoproteins decreased (p = 0.051) after either meal. The plasma concentrations of soluble inflammatory cytokines and adhesion molecules decreased (p < 0.01) independently of meal type, except for E-selectin, which decreased more (p = 0.033) after the walnut meal.
Adding walnuts to a high-fat meal acutely improves FMD independently of changes in oxidation, inflammation, or ADMA. Both walnuts and olive oil preserve the protective phenotype of endothelial cells.


Available from: Emilio Ros, Jan 30, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Walnut (Juglans regia) is a deciduous nut tree commercially grown in Jammu and Kashmir, Himachal Pradesh and hilly tracts of Uttar Pradesh in India. Walnuts are used for their edible fruit, their wood, and their health benefits, the most important being cholesterol-lowering properties. The Ladakh region of India, which includes Leh and Kargil districts of Jammu and Kashmir, is a cold arid region and climatic conditions are quite harsh. As the growing season is limited to five to six months, very limited increment in annual growth takes place. In the present study, an effort was made to investigate the different genotypes of walnut growing in and around Ladakh for phonological and pomological characters and to evaluate the superior genotype(s) for commercial exploitation at high altitudes of cold and arid region of India. Four genotypes were selected from the different walnut growing regions of Ladakh, namely Skara, Nurla, Temisgam and Dhomkhar. Each genotype was evaluated for plant morphological and leaf characters, nut and kernel characters, phenol, protein, carbohydrate and total oil content. Genotypes having intermediate to high tree vigour and spreading growth habit produced higher yield, and fairly good amounts of protein, carbohydrate and oil content were recorded in the dry kernels. Among the genotypes, protein content was high in Nurla (0.26 mg/g), oil content in Dhomkhar (82.30%) and carbohydrate and phenol content in Skara (0.23 mg/100 g, 2.84 mg/100 g, respectively). The productivity was highest in Temisgam (390 kg/tree) followed by Dhomkhar (335 kg/tree), Nurla (330 kg/tree) and lowest in Skara (315 kg/tree). It appears from the results that cultivars Temisgam and Nurla are most promising in terms of yield and biochemical composition and could be suggested for commercial exploitation of walnut in the Ladakh region of India.
    Proceedings of AFHW 2013 International Symposium on Agri-Foods for Health and Wealth August 5-8, 2013., Bangkok, Thailand; 08/2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study assessed the postprandial effects of high fat, high protein meals containing either palmolein or olive oil on endothelial function in overweight/obese men. 28 men (32-65 yr; 25-35 kg/m(2)) consumed, in random order 1 wk apart, isocaloric high protein, high fat meals (2791 kJ, 40 g protein (∼3 g l-arginine), 44 g fat, 21 g carbohydrate) prepared with either 40 g palmolein or 40 g olive oil after an overnight fast. The SFA:MUFA:PUFA ratio of the oils were: palmolein, 42:47:12; olive oil, 17:76:7. Brachial artery flow-mediated dilatation (FMD), circulating endothelial function markers, nitrotyrosine (oxidative stress marker), triglycerides, glucose and insulin were assessed pre-meal and hourly for 5 h. Mixed model procedures were used to analyze the data. Meal consumption increased serum triglycerides (time effect, P < 0.001); with no meal differences (meal × time interaction, P = 0.93). Serum insulin peaked 1 h post-consumption and returned to pre-meal concentrations by 5 h with both meals (time effect, P < 0.001; meal × time effect, P = 0.68). FMD, serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin did not change (meal × time effect, P > 0.4). Olive oil transiently increased plasma nitrotyrosine after 1 h compared to palmolein (meal × time interaction, P = 0.002) whereas both meals increased serum vascular cell adhesion molecule-1 (VCAM-1) after 1 h (time effect, P < 0.001; meal × time interaction, P = 0.98). Both nitrotyrosine and VCAM-1 returned to pre-meal concentrations after 2 h. In the context of a high protein meal, palmolein similarly to olive oil did not affect postprandial endothelial function in overweight/obese men. Australian New Zealand Clinical Trials Registry (ANZCTR) ( Trial ID: ACTRN12613000136707. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
    Atherosclerosis 01/2015; 239(1):178-185. DOI:10.1016/j.atherosclerosis.2015.01.009 · 3.97 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Although several studies have assessed the effects of nut consumption (tree nuts, peanuts, and soy nuts) on blood pressure (BP), the results are conflicting. The aim was to conduct a systematic review and meta-analysis of published randomized controlled trials (RCTs) to estimate the effect of nut consumption on BP. The databases MEDLINE, SCOPUS, ISI Web of Science, and Google Scholar were searched for RCTs carried out between 1958 and October 2013 that reported the effect of consuming single or mixed nuts (including walnuts, almonds, pistachios, cashews, hazelnuts, macadamia nuts, pecans, peanuts, and soy nuts) on systolic BP (SBP) or diastolic BP (DBP) as primary or secondary outcomes in adult populations aged ≥18 y. Relevant articles were identified by screening the abstracts and titles and the full text. Studies that evaluated the effects for <2 wk or in which the control group ingested different healthy oils were excluded. Mean ± SD changes in SBP and DBP in each treatment group were recorded for meta-analysis. Twenty-one RCTs met the inclusion criteria. Our findings suggest that nut consumption leads to a significant reduction in SBP in participants without type 2 diabetes [mean difference (MD): -1.29; 95% CI: -2.35, -0.22; P = 0.02] but not in the total population. Subgroup analyses of different nut types suggest that pistachios, but not other nuts, significantly reduce SBP (MD: -1.82; 95% CI: -2.97, -0.67; P = 0.002). Our study suggests that pistachios (MD: -0.80; 95% CI: -1.43, -0.17; P = 0.01) and mixed nuts (MD: -1.19; 95% CI: -2.35, -0.03; P = 0.04) have a significant reducing effect on DBP. We found no significant changes in DBP after the consumption of other nuts. Total nut consumption lowered SBP in participants without type 2 diabetes. Pistachios seemed to have the strongest effect on reducing SBP and DBP. Mixed nuts also reduced DBP. © 2015 American Society for Nutrition.
    American Journal of Clinical Nutrition 03/2015; 101(5). DOI:10.3945/ajcn.114.091595 · 6.92 Impact Factor